位置:首页 > 蛋白库 > 3SA2_NAJAT
3SA2_NAJAT
ID   3SA2_NAJAT              Reviewed;          81 AA.
AC   P01442;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-MAY-2022, entry version 116.
DE   RecName: Full=Cytotoxin 2;
DE   AltName: Full=Cardiotoxin 1A;
DE   AltName: Full=Cardiotoxin 2;
DE            Short=CTX-2 {ECO:0000303|PubMed:10708798};
DE   AltName: Full=Cardiotoxin A2 {ECO:0000303|PubMed:16407244, ECO:0000303|PubMed:8182052};
DE            Short=CTX A2 {ECO:0000303|PubMed:16407244, ECO:0000303|PubMed:8182052};
DE   AltName: Full=Cardiotoxin II {ECO:0000303|PubMed:8089116, ECO:0000303|PubMed:9425035};
DE   AltName: Full=Cardiotoxin analog II {ECO:0000303|PubMed:849468};
DE   Flags: Precursor;
OS   Naja atra (Chinese cobra).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Elapidae; Elapinae; Naja.
OX   NCBI_TaxID=8656;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RA   Chu R.C., Yang C.-C.;
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=10708798; DOI=10.1016/s0041-0101(99)00218-4;
RA   Chang L.-S., Huang H.-B., Lin S.-R.;
RT   "The multiplicity of cardiotoxins from Naja naja atra (Taiwan cobra)
RT   venom.";
RL   Toxicon 38:1065-1076(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 22-81, TOXIC DOSE, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=849468; DOI=10.1016/0005-2795(77)90040-x;
RA   Kaneda N., Sasaki T., Hayashi K.;
RT   "Primary structures of cardiotoxin analogues II and IV from the venom of
RT   Naja naja atra.";
RL   Biochim. Biophys. Acta 491:53-66(1977).
RN   [4]
RP   FUNCTION, AND APPARTENANCE TO S-TYPE CYTOTOXIN GROUP.
RX   PubMed=8182052; DOI=10.1016/s0021-9258(17)36647-4;
RA   Chien K.-Y., Chiang C.-M., Hseu Y.-C., Vyas A.A., Rule G.S., Wu W.-G.;
RT   "Two distinct types of cardiotoxin as revealed by the structure and
RT   activity relationship of their interaction with zwitterionic phospholipid
RT   dispersions.";
RL   J. Biol. Chem. 269:14473-14483(1994).
RN   [5]
RP   BINDING TO INTEGRIN ALPHA-V/BETA-3.
RX   PubMed=16407244; DOI=10.1074/jbc.m513035200;
RA   Wu P.-L., Lee S.-C., Chuang C.-C., Mori S., Akakura N., Wu W.-G.,
RA   Takada Y.;
RT   "Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and
RT   inhibits bone resorption. Identification of cardiotoxins as non-RGD
RT   integrin-binding proteins of the Ly-6 family.";
RL   J. Biol. Chem. 281:7937-7945(2006).
RN   [6]
RP   STRUCTURE BY NMR, AND DISULFIDE BONDS.
RX   PubMed=8089116; DOI=10.1016/s0021-9258(17)31544-2;
RA   Bhaskaran R., Huang C.C., Tsai Y.C., Chang K.D., Yu C.;
RT   "Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in
RT   solution and comparison among homologous cardiotoxins.";
RL   J. Biol. Chem. 269:23500-23508(1994).
RN   [7]
RP   STRUCTURE BY NMR, FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=9398182; DOI=10.1021/bi971107a;
RA   Jang J.-Y., Kumar T.K.S., Jayaraman G., Yang P.-W., Yu C.;
RT   "Comparison of the hemolytic activity and solution structures of two snake
RT   venom cardiotoxin analogues which only differ in their N-terminal amino
RT   acid.";
RL   Biochemistry 36:14635-14641(1997).
RN   [8]
RP   STRUCTURE BY NMR, AND DISULFIDE BONDS.
RX   PubMed=9425035; DOI=10.1021/bi971979c;
RA   Lee C.-S., Kumar T.K.S., Lian L.-Y., Cheng J.-W., Yu C.;
RT   "Main-chain dynamics of cardiotoxin II from Taiwan cobra (Naja naja atra)
RT   as studied by carbon-13 NMR at natural abundance: delineation of the role
RT   of functionally important residues.";
RL   Biochemistry 37:155-164(1998).
CC   -!- FUNCTION: Basic protein that binds to cell membrane and depolarizes
CC       cardiomyocytes. It also shows lytic activities, but 2-fold less
CC       important than that of CTX-A4. It binds to the integrin alpha-V/beta-3
CC       (ITGAV/ITGB3) with a moderate affinity. It may interact with sulfatides
CC       in the cell membrane which induces pore formation and cell
CC       internalization and is responsible for cytotoxicity in cardiomyocytes.
CC       It also may target the mitochondrial membrane and induce mitochondrial
CC       swelling and fragmentation. {ECO:0000269|PubMed:9398182}.
CC   -!- SUBUNIT: Monomer in solution; Homodimer and oligomer in the presence of
CC       negatively charged lipids forming a pore with a size ranging between 20
CC       and 30 Angstroms. {ECO:0000250|UniProtKB:P60301}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:849468}. Target cell
CC       membrane {ECO:0000250|UniProtKB:P60301}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland. {ECO:0000305}.
CC   -!- TOXIC DOSE: LD(50) is 2.1 mg/kg by intravenous injection into mice.
CC       {ECO:0000269|PubMed:849468}.
CC   -!- TOXIC DOSE: LD(50) is 56 mg/kg by subcutaneous injection into mice.
CC       {ECO:0000269|PubMed:849468}.
CC   -!- MISCELLANEOUS: Is classified as a S-type cytotoxin, since a serine
CC       residue stands at position 49 (Ser-29 in standard classification).
CC       {ECO:0000305|PubMed:8182052}.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Short-chain
CC       subfamily. Type IA cytotoxin sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U58485; AAB18381.1; -; mRNA.
DR   EMBL; U58481; AAB18377.1; -; mRNA.
DR   EMBL; AJ238734; CAB42054.1; -; Genomic_DNA.
DR   PIR; A01710; H3NJ2F.
DR   PDB; 1CRE; NMR; -; A=22-81.
DR   PDB; 1CRF; NMR; -; A=22-81.
DR   PDB; 4OM4; X-ray; 2.74 A; A/B/C/D/E=22-81.
DR   PDBsum; 1CRE; -.
DR   PDBsum; 1CRF; -.
DR   PDBsum; 4OM4; -.
DR   AlphaFoldDB; P01442; -.
DR   SMR; P01442; -.
DR   EvolutionaryTrace; P01442; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   CDD; cd00206; snake_toxin; 1.
DR   Gene3D; 2.10.60.10; -; 1.
DR   InterPro; IPR003572; Cytotoxin_Cobra.
DR   InterPro; IPR003571; Snake_3FTx.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR018354; Snake_toxin_con_site.
DR   PRINTS; PR00282; CYTOTOXIN.
DR   SUPFAM; SSF57302; SSF57302; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cardiotoxin; Cytolysis; Direct protein sequencing;
KW   Disulfide bond; Hemolysis; Membrane; Secreted; Signal;
KW   Target cell membrane; Target membrane; Toxin.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:849468"
FT   CHAIN           22..81
FT                   /note="Cytotoxin 2"
FT                   /evidence="ECO:0000269|PubMed:849468"
FT                   /id="PRO_0000035371"
FT   DISULFID        24..42
FT                   /evidence="ECO:0000269|PubMed:8089116,
FT                   ECO:0000269|PubMed:9398182, ECO:0000269|PubMed:9425035,
FT                   ECO:0000312|PDB:1CRE, ECO:0000312|PDB:1CRF,
FT                   ECO:0000312|PDB:4OM4"
FT   DISULFID        35..59
FT                   /evidence="ECO:0000269|PubMed:8089116,
FT                   ECO:0000269|PubMed:9398182, ECO:0000269|PubMed:9425035,
FT                   ECO:0000312|PDB:1CRE, ECO:0000312|PDB:1CRF,
FT                   ECO:0000312|PDB:4OM4"
FT   DISULFID        63..74
FT                   /evidence="ECO:0000269|PubMed:8089116,
FT                   ECO:0000269|PubMed:9398182, ECO:0000269|PubMed:9425035,
FT                   ECO:0000312|PDB:1CRE, ECO:0000312|PDB:1CRF,
FT                   ECO:0000312|PDB:4OM4"
FT   DISULFID        75..80
FT                   /evidence="ECO:0000269|PubMed:8089116,
FT                   ECO:0000269|PubMed:9398182, ECO:0000269|PubMed:9425035,
FT                   ECO:0000312|PDB:1CRE, ECO:0000312|PDB:1CRF,
FT                   ECO:0000312|PDB:4OM4"
FT   STRAND          23..25
FT                   /evidence="ECO:0007829|PDB:4OM4"
FT   TURN            27..30
FT                   /evidence="ECO:0007829|PDB:1CRE"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:4OM4"
FT   STRAND          41..47
FT                   /evidence="ECO:0007829|PDB:4OM4"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:1CRE"
FT   STRAND          55..62
FT                   /evidence="ECO:0007829|PDB:4OM4"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:4OM4"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:1CRE"
SQ   SEQUENCE   81 AA;  9041 MW;  182274E2FAD949BA CRC64;
     MKTLLLTLVV VTIVCLDLGY TLKCNKLVPL FYKTCPAGKN LCYKMFMVSN LTVPVKRGCI
     DVCPKNSALV KYVCCNTDRC N
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024